Newstral
Article
thelocal.ch on 2018-04-17 11:34
Switzerland's Novartis to inject $100 million into malaria drug research
Related news
- Novartis to inject $100m into malaria drug researchvanguardngr.com
- New Novartis drug takes aim at tough-to-treat malariatimesofmalta.com
- DNovartis Fights Malaria With $100mdailyguideafrica.com
- HNovartis, FDA Agree to Malaria Drug Trial Against COVID-19hamodia.com
- Switzerland's Novartis buys US biotech firm Spinifexabc3340.com
- Greek parliament set to launch bribes probe against Switzerland's Novartisthelocal.ch
- Strong US dollar hurts Q2 profits of Switzerland's NovartisTimesDaily.com
- FNovartis CEO: We need a different approach to drug discoveryfortune.com
- Novartis mulls spinning off Sandoz generic drug unittimesofmalta.com
- Bowing to Trump, Novartis Joins Pfizer in Freezing Drug PricesThe New York Times
- AMosquito research provides hope for malaria controlaugustafreepress.com
- Novartis drug firm faces Turkey bribe probethelocal.ch
- Novartis now has the most expensive drug ever after getting US approvalthelocal.ch
- MFirst it was Pfizer. Now Novartis has frozen drug prices in the USmoney.cnn.com
- Colombia battles Novartis over cancer drugThe Salt Lake Tribune
- Drug-resistant malaria 'spreads across Southeast Asia'CNN